A synthetic opioid is a painkilling chemical made entirely in a laboratory, without any ingredients derived from the opium poppy plant. Unlike morphine or codeine, which come directly from poppy sap, synthetic opioids are built from scratch using chemical precursors. Fentanyl, methadone, and tramadol are the most well-known examples. These drugs activate the same pain-relief pathways in the brain as natural opioids, but their lab-made structures can make them far more potent, and far more dangerous when misused.
How Synthetic Opioids Differ From Natural and Semi-Synthetic Ones
Opioids fall into three categories based on how they’re made. Natural opioids (often called opiates) are extracted directly from the opium poppy. Morphine, codeine, and thebaine are the main examples. Semi-synthetic opioids start with one of those natural compounds and then get chemically modified in a lab. Heroin was the first semi-synthetic opioid, created by altering morphine’s structure. Oxycodone and hydrocodone also fall into this category.
Synthetic opioids are structurally different from all of these. They don’t begin with poppy-derived material at all. Chemists design them from basic chemical building blocks to interact with the same brain receptors that morphine targets. This gives manufacturers precise control over the drug’s properties, including how quickly it takes effect, how long it lasts, and how powerful it is. That flexibility is why synthetic opioids range from relatively mild (tramadol) to extraordinarily potent (fentanyl and its analogs).
How They Work in the Body
All opioids, whether natural or synthetic, work by binding to a specific receptor in the brain and spinal cord called the mu-opioid receptor. When a molecule locks into this receptor, it triggers pain relief, sedation, and feelings of euphoria. It also slows breathing, which is the primary cause of overdose deaths.
What’s notable is that synthetic opioids don’t just do the same thing as morphine more efficiently. Research published in the Journal of Chemical Information and Modeling found that fentanyl binds to the mu-opioid receptor in a completely different physical orientation than morphine does. This different binding position triggers stronger activation of the parts of the receptor most critical to its signaling. In practical terms, fentanyl flips the receptor’s “on switch” more forcefully than morphine can, which helps explain why a tiny amount produces such intense effects.
Potency Compared to Other Opioids
The defining feature of many synthetic opioids is their extreme potency relative to older drugs. Fentanyl is roughly 50 times more potent than heroin and about 100 times more potent than morphine. In clinical settings, a fentanyl patch delivering just 25 micrograms per hour provides pain relief equivalent to 60 milligrams of oral morphine per day. That ratio means even microscopic measurement errors can be lethal.
Newer synthetic opioids called nitazenes push potency even further. Originally developed by pharmaceutical companies in the 1950s but never approved as medicines, nitazenes have resurfaced in illicit drug markets. Some of the most potent variants include isotonitazene, which is roughly 250 times stronger than heroin (about five times more potent than fentanyl), and etonitazene, estimated at 500 times heroin’s strength. These drugs have been detected in substances sold as other opioids, benzodiazepines, and even cannabis products in parts of Europe.
Medical Uses
Several synthetic opioids have legitimate and important roles in medicine. Fentanyl is widely used for surgical anesthesia and for managing severe pain in cancer patients, typically delivered through skin patches or lozenges. Its rapid onset and short duration make it useful in controlled medical settings where precise dosing is possible.
Methadone serves a dual purpose. It’s prescribed for pain management and is also one of the primary medications used to treat opioid use disorder. Because methadone is long-acting, it helps reduce cravings and withdrawal symptoms without producing the intense high associated with shorter-acting opioids. Tramadol is a milder synthetic opioid commonly prescribed for moderate pain, though it still carries addiction risk.
The Illicit Supply
The synthetic opioid crisis is driven largely by illegally manufactured fentanyl and its analogs. Unlike heroin, which requires opium poppy cultivation, fentanyl can be synthesized in a standard chemistry lab using commercially available precursor chemicals. The United Nations Office on Drugs and Crime has worked to restrict international trade in several key precursors, placing five of them under formal international control. These include compounds used in the most common fentanyl synthesis routes.
The appeal for illicit manufacturers is straightforward: because fentanyl is active in microgram quantities, a small amount of raw material produces an enormous number of doses. It’s cheaper to make, easier to transport, and more profitable than plant-based drugs. Illicit fentanyl is frequently pressed into counterfeit pills designed to look like prescription oxycodone or alprazolam, or mixed into heroin, cocaine, and other street drugs. People using these substances often have no idea fentanyl is present.
The Scale of Overdose Deaths
Synthetic opioids are the leading driver of drug overdose deaths in the United States. In 2024, 47,735 Americans died from overdoses involving synthetic opioids other than methadone (a category that primarily captures fentanyl and its analogs). That figure represents the single largest share of the 79,384 total drug overdose deaths recorded that year.
There is some encouraging movement in the numbers. Synthetic opioid deaths dropped 35.6% from 2023 to 2024, the largest decline among any drug category. The overall age-adjusted overdose death rate fell to 23.1 per 100,000 people. Experts point to expanded access to naloxone, increased awareness, and harm reduction programs as contributing factors, though the death toll remains historically high.
Reversing a Synthetic Opioid Overdose
Naloxone, the emergency medication that reverses opioid overdoses, works against synthetic opioids, but the high potency of drugs like fentanyl complicates rescue efforts. First responders increasingly report needing multiple doses of naloxone to revive someone who has overdosed on fentanyl, whereas a single dose was typically sufficient for heroin overdoses.
Newer naloxone products have been developed specifically for this challenge. Higher-dose formulations, including 8-milligram nasal sprays and 5-milligram prefilled injections, are now available. Simulations and field reports suggest these stronger preparations are better matched to the reality of synthetic opioid overdoses, where the amount of drug in the body may overwhelm standard naloxone doses. For nitazenes, naloxone is still expected to work, but the even greater potency of these compounds means that still higher or repeated doses may be necessary.
The key principle remains the same: naloxone buys time by temporarily blocking opioids from the brain’s receptors. Because fentanyl and nitazenes may outlast a single dose of naloxone, someone who has been revived can slip back into respiratory depression as the naloxone wears off. Staying with the person and being prepared to give additional doses is critical.